ProCE Banner Activity

Preventing Recurrent VTE in Persons with Obesity

Clinical Thought

Compared to persons with normal BMI, those with obesity are at higher risk of having a VTE event. Here’s my approach to minimizing recurrence after an initial VTE.

Released: May 09, 2022

Expiration: May 08, 2023

No longer available for credit.



Christian T. Ruff

Christian T. Ruff, MD, MPH

Associate Professor of Medicine
Harvard Medical School
Director of General Cardiology
Brigham and Women's Hospital
Boston, Massachusetts


This activity is supported by educational grants from the Bristol Myers Squibb and Pfizer Alliance; and Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.

Provided by

ProCE Banner


Bristol Myers Squibb

Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.

Pfizer Alliance

Target Audience

NPs and PAs in primary care


Dr Ruff: consultant/advisor/speaker: Anthos, Bayer, Bristol-Myers Squibb, Janssen, Pfizer; researcher: Anthos, AstraZeneca, National Institutes of Health; researcher/consultant/advisor/speaker: Boehringer Ingelheim, Daiichi Sankyo.

None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.


Clinical Thought


The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.

Additional Information

Program Medium

This program has been made available online.